- Home
- / Laurus Labs
Laurus Labs
Stock Price
₹488.6
2024-10-29
Market Capitalization
₹263.9 B
2024-10-29
Revenue
₹68.1 B
FY, 2026
Laurus Labs Summary
Company Summary
- Overview
- Laurus Labs is a pharmaceutical company. Its business units include Generics API, Generics FDF, Ingredients, and Synthesis. Through its business units, the company provides specialty ingredients for the nutraceutical and allied industries.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Hyderabad, IN | view all locations
- Website
- https://lauruslabs.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
M Venu Gopala Rao, Non-Executive Chairman and Independent Director
Ravi Kumar, Executive Director & Chief Financial Officer
Lakshman Chunduru, Executive Director – Quality
LocationsView all
15 locations detected
Hyderabad, TG HQ
India
2nd Floor, Serene Chambers, Road No 7
Berkeley Heights, NJ
United States
400 Connell Dr #5200
Wilmington, DE
United States
200 Bellevue Pkwy #210
Hamburg, HH
Germany
Van-der-Smissen-Straße 1
Turkapally, TG
India
Plot No: DS1, IKP Knowledge Park, Genome Valley
Visakhapatnam, AP
India
Plot No: 102 & 103, SEZ
Laurus Labs Financials
Summary Financials
- Revenue (FY, 2026)
- ₹68.1B
- Gross profit (FY, 2026)
- ₹41.7B
- Net income (FY, 2026)
- ₹8.9B
- Cash (FY, 2026)
- ₹1.1B
- EBIT (FY, 2026)
- ₹13.5B
- Enterprise value
- $285.4B